Chemotherapy does not normally work on sporadic kidney cancer. This type of cancer appears to be extremely resistant to chemotherapy. There are several clinical trials being conducted with chemotherapy to try and improve its effectiveness as a treatment for kidney cancer. These trials involve testing the effectiveness of chemotherapy either alone or in combination with other therapies, and are not at present geared towards those affected by BHD syndrome.